We are live on
!
Find out more
Macquarie Group Portfolio holdings
AUM
$16.8B
1-Year Est. Return
27.39%
This Fund
S&P 500
This Quarter
Est. Return
-14.21%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$89.1B
AUM Growth
+$88.9B
(+67,641%)
Cap. Flow
-$3.22B
Cap. Flow
% of AUM
-3.61%
Top 10 Holdings %
Top 10 Hldgs %
11.59%
Holding
2,672
New
86
Increased
706
Reduced
853
Closed
108
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$324M |
| 2 |
Meta Platforms (Facebook)
META
|
+$263M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$175M |
| 4 |
NextEra Energy
NEE
|
+$132M |
| 5 |
Snap
SNAP
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$504M |
| 2 |
Apple
AAPL
|
+$433M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$248M |
| 4 |
Viatris
VTRS
|
+$241M |
| 5 |
Amazon
AMZN
|
+$210M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.36% |
| 2 | Healthcare | 15.43% |
| 3 | Financials | 13.5% |
| 4 | Industrials | 10.21% |
| 5 | Consumer Discretionary | 9.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LGF.B
1426
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $1.01M | ﹤0.01% |
114,808
-1,511
| -1% | -$17.2K |
|
1427
XPeng
XPEV
$12.2B
| $1.01M | ﹤0.01% |
31,778
-583
| -2% | -$15K |
|
|
OSH
1428
DELISTED
Oak Street Health, Inc.
OSH
| $1.01M | ﹤0.01% |
61,321
+2,053
| +3% | +$39.9K |
|
1429
Nektar Therapeutics
NKTR
$2.41B
| $999K | ﹤0.01% |
17,523
| – | – |
|
1430
Winnebago Industries
WGO
$879M
| $990K | ﹤0.01% |
20,391
| – | – |
|
|
FINM
1431
DELISTED
Marlin Technology Corporation Class A Ordinary Share
FINM
| $987K | ﹤0.01% |
100,000
| – | – |
|
1432
Xerox
XRX
$357M
| $983K | ﹤0.01% |
66,184
| – | – |
|
1433
Acco Brands
ACCO
$381M
| $981K | ﹤0.01% |
150,227
| – | – |
|
1434
Teleflex
TFX
$5.8B
| $977K | ﹤0.01% |
3,969
+32
| +0.8% | +$9.33K |
|
1435
SL Green Realty
SLG
$3.83B
| $976K | ﹤0.01% |
20,169
-114,055
| -85% | -$7.25M |
|
1436
Ethan Allen Interiors
ETD
$592M
| $968K | ﹤0.01% |
47,864
-14,182
| -23% | -$335K |
|
|
TWTR
1437
DELISTED
Twitter, Inc.
TWTR
| $968K | ﹤0.01% |
25,872
-473
| -2% | -$20.3K |
|
1438
Gartner
IT
$9.87B
| $966K | ﹤0.01% |
3,997
| – | – |
|
1439
Baker Hughes
BKR
$60.1B
| $959K | ﹤0.01% |
33,193
-7,801
| -19% | -$264K |
|
1440
ICICI Bank
IBN
$107B
| $959K | ﹤0.01% |
54,077
-48,033
| -47% | -$898K |
|
|
KW
1441
DELISTED
Kennedy-Wilson Holdings
KW
| $955K | ﹤0.01% |
47,570
-22,312
| -32% | -$480K |
|
1442
Viking Therapeutics
VKTX
$4.05B
| $954K | ﹤0.01% |
330,100
-1,948
| -0.6% | -$4.82K |
|
|
ODP
1443
DELISTED
ODP
ODP
| $953K | ﹤0.01% |
31,516
| – | – |
|
1444
AMC Global Media
AMCX
$445M
| $949K | ﹤0.01% |
32,598
| – | – |
|
|
CTO
1445
CTO Realty Growth
CTO
$744M
| $947K | ﹤0.01% |
+46,500
| New | +$977K |
|
1446
Victory Capital Holdings
VCTR
$6.23B
| $947K | ﹤0.01% |
39,300
| – | – |
|
1447
Twist Bioscience
TWST
$5.39B
| $946K | ﹤0.01% |
27,059
-2,329
| -8% | -$82.5K |
|
1448
Energizer
ENR
$1.44B
| $934K | ﹤0.01% |
32,952
| – | – |
|
1449
Smith & Wesson
SWBI
$666M
| $934K | ﹤0.01% |
71,185
| – | – |
|
|
REVG
1450
DELISTED
REV Group
REVG
| $933K | ﹤0.01% |
85,876
| – | – |
|
Similar funds
AIMCA
CI
BCIM
VMPIC
EIP
PP
ASRS
CM
Macquarie Group's Q2 2022 Portfolio in Review
As of Q2 2022, Macquarie Group held 2,672 positions worth $89.1B, up 67,641% from $131M the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Macquarie Group withdrew a net $3.22B in Q2 2022, closing 108 positions and reducing 853 holdings. Its most notable exit was Healthcare Realty, an estimated $10.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Macquarie Group opened a new position in Petco worth $56.3M.
- Macquarie Group's largest Q2 2022 buy was Petco: 3,818,489 shares worth $56.3M.
- Macquarie Group added most to Hologic in Q2 2022, an estimated $324M increase.
- Macquarie Group's biggest Q2 2022 reduction was Microsoft, cutting an estimated $504M.
- Macquarie Group fully exited Healthcare Realty in Q2 2022, selling an estimated $10.8M.
- Macquarie Group's ten largest holdings make up 12% of its $89.1B portfolio in Q2 2022.
- Macquarie Group opened 86 new positions and closed 108 in Q2 2022.
- Macquarie Group's portfolio value rose 67,641% quarter-over-quarter to $89.1B.
Based on Macquarie Group's 13F filing for Q2 2022, filed 15 Aug 2022.